Weed Inc - BUDZ stock

Introduction

WEED, Inc., along with its subsidiary companies, is dedicated to researching and utilizing compounds derived from cannabis for the purpose of addressing human diseases and animal health issues. The company engages in various activities, including the cultivation and harvesting of cannabis and hemp for research, product development, processing, manufacturing, and the sale of pharmaceutical and non-pharmaceutical products. These products, services, therapeutics, and treatments are intended for medical applications. Previously known as United Mines, Inc., the company underwent a name change in February 2015 to become WEED, Inc. It was established in 1999 and has its headquarters in Tucson, Arizona.

History

An initial public offering in 2021 was for up to 40,000,000 units at $1 each, with a unit consisting of one share and one warrant with an exercise price of 150% of the price paid for the unit.

For 2,000,000 shares of common stock at $.25 per share plus $250,000 in cash WEED, Inc. acquired 100% of Hempirical Genetics, LLC. One million shares and $10,000 in cash were transferred upon signing the agreement, with the remainder to be paid over four years. With this arrangement, WEED obtained over 250 proprietary cannabis & hemp strains.

Strategy

WEED, Inc. is a worldwide, diversified, vertically integrated, best-in-class cannabis business, and its objective is to find, develop, and employ compounds derived from cannabis and hemp for the treatment of human and animal ailments. The mission of WEED, Inc. is to build a name for itself in the cannabis and hemp industries that is recognized on a global scale through the creation, acquisition, and ownership of related intellectual assets. These assets include patents, trademarks, copyrights, licenses, and cannabis-based products. To develop and promote the WEED, Inc. brand, the company is structured as a holding company that runs its operations via its divisions, completely owned subsidiaries, and collaboratively located partners in other businesses. When it comes to the Cannabaceae plant family, WEED, Inc. is totally dedicated to its global objective of developing, commercializing, and distributing remedies, medical therapies, and products that are derived from the whole plant.

Operations

WEED Inc. has operations in Australia, United States, and Israel.

The company sold it's 4 acre Sangre Biosciences facility in Colorado for $1.8 million, and it's headquarters for $1.34 million. These proceeds are expected to be used for strategic acquisitions and expansion of testing facilities and a cGMP certified kitchen to produce CPGs under HEMP BioSciences Inc. in Arizona.

The WEED Inc. Management Team

• WEED, Inc. is led by co-founder and President/CEO Glenn E. Martin. Mr. Martin, a recognized authority on the cannabis sector as a whole, has led the expansion of WEED, Inc. into a global powerhouse.
• WEED, Inc. was co-founded by Ms Nicole M. Breen, who also serves as the company's Corporate Secretary and Treasurer as of September 30, 2014.
• Besides leading WEED Australia Ltd, Managing Director Patrick Brodnik also serves as Co-Managing Director of the Cannabis Institute of Australia.
• WEED Israel (Cannabis) Ltd. is led by Elliot Kwestel, who also serves as the company's director and secretary.
• Elliott received his Bachelor of Science in Computer Science from Yeshiva University and his Master of Business Administration in Organizational Behavior from Ono Academic College. He has more than 15 years of expertise in the fields of technology and finance, and he is a former software engineer.

Intellectual Capital

The value of a company's intellectual property has recently been acknowledged as rivaling that of the company's physical assets. The goal of WEED, Inc.'s intellectual property (IP) strategy is to increase the company's value via the creation and purchase of many IP assets such as brands, patents, trademarks, copyrights, and licenses. It's common knowledge that a company's brand is one of its most valuable resources. The ability of a company's brand to set it apart from competitors is crucial to the company's success. A brand's value proposition must be communicated quickly and clearly to consumers. A successful brand is one that is trusted, sought after, and most of all, easily identifiable. WEED, Inc. (OTCMKTS: BUDZ) is the most well-known company in the rapidly expanding global cannabis business. Through its subsidiaries and affiliates, WEED, Inc. is developing a comprehensive portfolio of brands, patents, trademarks, copyrights, and licenses. When it comes to intellectual property, WEED, Inc.'s medical cannabis focus is on compiling a library of the most effective medicinal strains via study, identification, collecting, patenting, and archiving. With the goal of obtaining and maintaining monopoly over the IP/Branding of preexisting patents, trademarks, copyrights, and licenses, WEED, Inc. will continue to increase the breadth of its intellectual capital portfolio via its subsidiaries. To finish drawing up the genetic code for the cannabis plant genus, WEED, Inc. has begun a five-year Cannabis Genomic Study. WEED, Inc. is well-positioned to dominate the market as the cannabis industry enters a new era of discovery about the strain-specific sequencing of DNA, identification of pathogens, and elucidation of metabolic pathways.

Research and Development Strategy

Methodology for New Product Development

The goal of WEED Inc.'s research and development of new patents, products, and therapies generated from cannabis and hemp is to enhance the standard of living for sentient beings of all kinds.

Click the button to add BUDZ to the list of your stock picks.

Pick this!

Recently Updated Wikis

• GLATF
  Global Atomic Corp
• JSDA
  Jones Soda Co
• ILIKF
  Ilika Plc
• VPER
  Viper Networks Inc
• KRRGF
  Karora Resources Inc
• IPOOF
  Inplay Oil Corp
• ACRHF
  Acreage Holdings Inc
• AMYZF
  RecycLiCo Battery Materials Inc
• AXIM
  Axim Biotechnologies Inc
• OTLC
  Oncotelic Therapeutics Inc

OTC Symbol: BUDZ | OTC Tier: OTCQB